title: [Cephalosporins in empirical treatment of neutropenic fever].
abstract: Neutropenic fever and infection became a significant clinical problem with the common use of chemotherapy of cancer. The cephalosporins are a large group of beta-lactam antimicrobial agents. Because of their broad spectrum of activity and low toxicity, they are excellent choice for initial empirical treatment of fever in neutropenia. The article summarises the role of third and fourth generation cephalosporins in therapy of neutropenic fever.
authors.affiliation: Katedra i Klinika Hematologii i Chorób Rozrostowych Akademii Medycznej we Wroclawiu.
authors.forename: T
authors.initials: T
authors.lastname: Wróbel
authors.forename: G
authors.initials: G
authors.lastname: Mazur
authors.forename: K
authors.initials: K
authors.lastname: Kuliczkowski
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005334:Fever / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D002511:Cephalosporins